Rankings
▼
Calendar
SLDB Q4 2023 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena
SLDB
Solid Biosciences Inc.
$644M
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$22M
Net Income
-$20M
EPS (Diluted)
$-0.70
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$21M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$165M
Total Liabilities
$38M
Stockholders' Equity
$126M
Cash & Equivalents
$74M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$22M
-$35M
+35.6%
Net Income
-$20M
-$15M
-34.2%
← FY 2023
All Quarters
Q1 2024 →